Teva recalls Metoclopramide Tablets, USP, 5 mg over foreign tablets or capsules found in product
The notice says some bottles of these tablets contain foreign tablets or capsules, and it does not describe any effect on a person.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05
- Hazard
- Presence of Foreign Tablets/Capsules
- Units
- 240,448 cartons
- Where sold
- US Nationwide.
- FDA classification
- Class II · Ongoing
- Classified by FDA
- October 13, 2026
- Recall started
- September 29, 2026
- FDA enforcement report
- October 21, 2026
- Identifiers
- Codes: Lot, expiry: [100 Tablets] Lots 8634085, 8635085, 8636085, exp 07/2027; [500 Tablets] Lot 8633085, exp 07/2027
- FDA recall number: D-0038-2027
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05
- Reason for recall
- Presence of Foreign Tablets/Capsules
- Classification
- Class II (Ongoing)
- Distribution
- US Nationwide.
- Quantity
- 240,448 cartons
Related recalls
Teva recalls trazodone 50 mg tablets over foreign tablets or capsules found in bottles
The notice says some bottles of these trazodone tablets, a prescription medicine, contain foreign tablets or capsules, so a bottle may hold pills that are not trazodone.
Teva Pharmaceuticals USA, Inc · 175,392 bottles
Teva recalls metoprolol succinate extended-release tablets because they failed dissolution testing
The tablets failed dissolution specifications, which are tests of how the medicine is released from the pill, and the notice does not describe any other risk.
Teva Pharmaceuticals USA, Inc · 112,327 units
Teva recalls isotretinoin capsules (30 mg and 40 mg) because some may be too strong or too weak
Some of the isotretinoin capsules were found to be either stronger or weaker than labeled, so patients may get more or less medicine than their prescription calls for.
Teva Pharmaceuticals USA, Inc · 30,360 units
American Health Packaging recalls Metoclopramide Tablets, USP, 5 mg over foreign tablets or capsules found
The notice says the recalled Metoclopramide Tablets, USP, 5 mg may contain foreign tablets or capsules, and it covers 5,363 cartons sold across the US.
American Health Packaging · 5,363 cartons